Adjunctive therapy with low molecular weight heparin with recombinant tissue-type plasminogen activator causes sustained reflow in canine coronary thrombosis

This publication has 31 references indexed in Scilit:

• Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis
  Cardiovascular Research, 1991
• Guidelines for the early management of patients with acute myocardial infarction
  Journal of the American College of Cardiology, 1990
• Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in Rabbitsa
  Annals of the New York Academy of Sciences, 1989
• RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2
  Published by Elsevier ,1988
• A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysis
  American Heart Journal, 1987
• Coronary Angioscopy in Patients with Unstable Angina Pectoris
  New England Journal of Medicine, 1986
• Frequency of intracoronary filling defects by angiography in Angina pectoris at rest
  The American Journal of Cardiology, 1985
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.
  Circulation, 1985